Showing posts with label ALS. Show all posts
Showing posts with label ALS. Show all posts

Dec 17, 2010

Senate: $11.8 million for Gulf War related health research in Omnibus

By Anthony Hardie, 91outcomes

(91outcomes.com) - According to a key staff member in the office of U.S. Senator Bernie Sanders (I-Vt.), a longtime, leading champion of Gulf War Illness treatment research and other Gulf War related efforts in the U.S. Senate:

Here is what I found in the most recent FY 2011 Omnibus DOD Appropriations currently under consideration.

Provides $8 million for the Peer Reviewed Gulf War Illness Research Program and $3.8 million for the ALS Therapy Development Institute Gulf War Research Project.
This will ensure continued funding at this year’s level, a wonderful outcome that is even more exceptional given the current challenges facing a lame duck Congress trying to get a lot done in a matter of days left before the end of the year.

And, General “Mic” would probably have been pleased to see this continued, designated funding for Gulf War related ALS funding.

So, in total, it appears highly likely that the FY11 funding for Gulf War related research in the CDMRP will be at $13.8 million, as described above. Excellent news!

And, according to another key Hill insider from one of the leading veterans service organizations on this issue:

We have no influence on the current funding levels (they have been set by CBO and will not be impacted).

Putting all of our energy into planning a concerted effort to influence the next Authorization funding cycle will be a much more worthy endeavor.

In everyone’s opinion [on the Hill, this year’s GWI funding level] is set in stone at this point.
As noted in the 91outcomes’ earlier article, the House version already had a provision ensuring that DoD funding continues, for the most part, at FY10 levels. As such, this includes $8 million for the peer reviewed $8 million Gulf War Illness research program.

And, if the Senate should also change course from the proposed “omnibus” appropriations act and move to a “clean” Continuing Resolution like the House has already passed, this will also result in the same funding outcomes for CDMRP Gulf War related health research.

So, good news all around!

NEXT YEAR:

Now is the time to begin thinking about preparing for a concerted effort in the next Congress to seek increased funding for DoD-Army-CDMRP GWI research.

Given the possibility of new inter-agency, inter-institution research consortiums being funded, having a coordinated message by all organizations and individuals contacting Congress will be of critical importance.

WHAT NOT TO DO TODAY:

Fragmented messages and random calls by individuals not really clear on what it is for which they’re asking has the strong potential of derailing efforts.

Anything perceived by members and staff in Congress as having a lack of clear unity on a particular issue -- like CDMRP GWI funding -- can lead to lots of calls and confusion and result in that particular issue – like CDMRP GWI funding -- to be left in the “too hard to do” category and left off from funding entirely.

And, the current “CR” and omnibus appropriations bills do not contain “line items” for these research programs – they’re mostly “clean” bills that simply say to continue funding across the board at last year’s levels.

This also means that there is little if any possibility of changing funding from last year’s levels.

WHAT TO DO TODAY:

So for now, individuals interested in contacting their members of Congress should simply say, “thank you” for the continued funding at this year’s level for all programs, including the DoD-Army-CDMRP peer reviewed Gulf War Illness research program.

WHAT TO DO AFTER JANUARY 3RD:

Stay tuned here on 91outcomes for updates on concerted efforts in the next Congress, which begins in January.

It will be important that Gulf War veterans speak with one voice on these critically important issues, particularly with the possibility of a need to fund consortiums with FY12 funding.

Dec 1, 2007

Stem Cell Advance Shows More Research Needed, Not Less



Madison, Wisconsin - James A. Thomson, the UW-Madison scientist who led the team that announced in 1998 the generation of stem cells from human embryonic cells, is an admired figure across the world.

Stem cells can become any of the differentiated cells of the human body and hold the promise to developing treatments and possibly cures for such ailments as diabetes, muscular dystrophy, amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease), and other degenerative conditions.

The possibilities are staggering, and stem cells are hope for the millions of people suffering from cruel and life-destroying illnesses.

Unfortunately, the same small band of rigid, anti-rational dogmatists (which includes President George W. Bush) who rave against federal funding for embryonic stem cell research in favor of Bush's stem cell policy, have now declared the issue moot after the announcement in November of Dr. Thomson’s and a Japanese team’s generation of stem cells from adult, non-embryonic cells.

Representative of this clique is Charles Krauthammer.

Krauthammer quotes Dr. Thomson: “If human embryonic stem cell research does not make you at least a little bit uncomfortable, you have not thought about it enough.”

Krauthammer goes on to praise President Bush and his unyielding opposition to embryonic stem cell research.

The verdict is clear: Rarely has a president -- so vilified for a moral stance -- been so thoroughly vindicated. … Because the moral disquiet that James Thomson always felt -- and that George Bush forced the country to confront -- helped lead him and others to find some ethically neutral way to produce stem cells. Providence then saw to it that the technique be so elegant and beautiful that scientific reasons alone will now incline even the most willful researchers to leave the human embryo alone.

Ridiculous.

Judicious researchers like Dr. Thomson have thought through the moral implications of using days-old, tiny embryonic cells (destined to be destroyed at fertility clinics) to generate stem cells, and have arrived at the opposite conclusion from that which Krauthammer and the religious right disingenuously posit.

Stem cell research is in its infancy and though the research has been set back years by Bush’s stubborn policy, no stem cell researcher is calling for the abandonment of embryonic stem cell research.

The new stem cell techniques are brand-new, retain possible cancer-causing risks, and would be unsuitable at this point for any therapy, much less cures.

The arguments against embryonic stem cell research were irrational when Bush and the religious right made them in 2001, and they remain so today.

The small circle of anti-embryonic stem cell research fanatics should be seen as the cruel Luddites that they are.

No compromise need be made with this tiny minority of the American public.

The promise and hope of scientific inquiry generally and stem cell research specifically should be rekindled by the next American administration.

Embryonic stem cell research and new techniques ought to become the Manhattan Project for the next century.

###